Skip to main contentSkip to navigation
Sirius Investors
Covalon Technologies Ltd.

Covalon Technologies Ltd.

CVALF
OTCHealthcare

Covalon Technologies Ltd. (CVALF) Investment Research Dashboard

About Covalon Technologies Ltd. (CVALF) stock analysis

Get live CVALF stock price $1.57, comprehensive Covalon Technologies Ltd. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time CVALF stock data and investment insights.

1.57
1.42%Today
Market Cap
43.42M
Volume
1.00K
52W High
2.14
52W Low
1.16

Loading chart data...

Covalon Technologies Ltd. (CVALF) Overview

Covalon Technologies Ltd. (CVALF) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, CVALF trades at $1.57 with a market capitalization of 43.42M . Over the past 52 weeks, CVALF has traded between $1.16 and $2.14 , with the current price positioned at approximately 42% of this range . The stock currently tra...

Key Takeaways

  • Operates in the Healthcare sector (Biotechnology)
  • Market cap: 43.42M
  • Current price: $1.57
  • 52-week range: $1.16 - $2.14
  • P/E ratio: 34.95

Investment Score

TTM (current)
Unavailable

A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Covalon Technologies Ltd. is a global medical technology firm specializing in the innovation, production, commercialization, and licensing of medical solutions across the United States, Canada, Europe, the Middle East, Asia, and Latin America. The co...

Company Information

CEO
Brent Ashton
Sector
Healthcare
Industry
Biotechnology
Employees
105

Contact Information

Address
1660 Tech Avenue
Country
CA

Investment Analysis & Business Insights

Healthcare
Biotechnology

Investment Highlights

Strong presence in the Healthcare sector with established market position

Growth-oriented company with premium valuation (P/E: 35.0)

Lower volatility stock (Beta: 0.03) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Covalon Technologies Ltd. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Covalon Technologies Ltd.
  • Investors should consider how Covalon Technologies Ltd. fits within their overall portfolio allocation
  • Premium valuation (P/E: 35.0) requires strong growth to justify

Market Cap

43.42M

P/E Ratio (TTM)

34.95

Beta

0.03

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

85/100 ⭐⭐⭐⭐⭐

Overall
+0.2%
NYSE
+0.4%
NASDAQ
+0.1%
Sector1D1W1MP/EScore
Financial Services-0.1%+3.3%+3.7%19.1
97/100⭐⭐⭐⭐⭐
Healthcare+0.2%+2.8%+3.0%24.1
85/100⭐⭐⭐⭐⭐
Communication Services-0.3%+1.2%+2.6%22.2
75/100⭐⭐⭐⭐⭐
Consumer Defensive+0.4%+2.3%+1.9%29.8
65/100⭐⭐⭐⭐
Real Estate-0.8%-0.4%-1.9%29.0
50/100⭐⭐⭐
Basic Materials-1.2%-0.5%-1.9%25.0
46/100⭐⭐⭐
Energy-0.0%-3.8%-3.1%19.5
43/100⭐⭐⭐
Utilities-0.8%-2.8%-5.7%26.3
32/100⭐⭐
Consumer Cyclical+0.3%-0.6%-6.5%42.7
24/100
Industrials-1.4%-0.3%-12.9%29.5
20/100
Technology-0.3%-3.2%-10.4%40.6
12/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.